The first Biogen trade was made in Q1 2014.
Since then Ron Baron bought shares eleven more times and sold shares on five occasions. The investor sold all their shares in Q1 2019 and doesn't own any shares in Biogen anymore.
Avg closing price
Price range
Sold -10.2 Thousand shares
Q1 2019
Avg closing price
$314.89
Price range
$216.71
-
$338.96
Increased shares by 0.9% (+90 shares)
Q3 2018
Avg closing price
$344.30
Price range
$293.51
-
$383.83
Sold 41.3% shares (-7.11 Thousand shares)
Q2 2018
Avg closing price
$281.15
Price range
$257.52
-
$306.91
Increased shares by 15.6% (+2.33 Thousand shares)
Q1 2018
Avg closing price
$310.41
Price range
$260.13
-
$367.91
Increased shares by 14.8% (+1.92 Thousand shares)
Q4 2017
Avg closing price
$320.80
Price range
$307.64
-
$344.58
Increased shares by 0.1% (+16 shares)
Q3 2017
Avg closing price
$296.11
Price range
$271.76
-
$329.69
Increased shares by 95.2% (+6.31 Thousand shares)
Q2 2017
Avg closing price
$264.42
Price range
$246.54
-
$286.89
Increased shares by 0.7% (+48 shares)
Q4 2016
Avg closing price
$272.86
Price range
$251.75
-
$298.61
Sold 66.5% shares (-13 Thousand shares)
Q3 2016
Avg closing price
$272.63
Price range
$222.79
-
$303.87
Increased shares by 22.3% (+3.57 Thousand shares)
Q2 2016
Avg closing price
$242.59
Price range
$206.74
-
$267.16
Increased shares by 56.7% (+5.81 Thousand shares)
Q1 2016
Avg closing price
$243.15
Price range
$225.62
-
$273.11
Sold 13.3% shares (-1.57 Thousand shares)
Q4 2015
Avg closing price
$264.50
Price range
$235.68
-
$285.05
Increased shares by 29.2% (+2.67 Thousand shares)
Q3 2015
Avg closing price
$303.98
Price range
$250.63
-
$376.94
Increased shares by 6.2% (+531 shares)
Q4 2014
Avg closing price
$297.80
Price range
$275.32
-
$332.00
Sold 0.2% shares (-19 shares)
Q3 2014
Avg closing price
$303.25
Price range
$275.50
-
$318.77
Increased shares by 41.8% (+2.54 Thousand shares)
Q2 2014